Azobenzenes

eMolecules​ Ambeed / (4S5S)-2-(2-(Diphenylphosphanyl)phenyl)-45-diphenyl-45-dihydrooxazole / 100mg / 633660447 / A1352088 / / 1918125-85-5 / [null] / 483.551 / C33H26NOP

Ambeed / (4S5S)-2-(2-(Diphenylphosphanyl)phenyl)-45-diphenyl-45-dihydrooxazole / 100mg / 633660447 / A1352088 / / 1918125-85-5 / [null] / 483.551 / C33H26NOP

eMolecules​ Ambeed / (4R5R)-45-Diphenyl-2-(5-(trifluoromethyl)pyridin-2-yl)-45-dihydrooxazole / 100mg / 633418067 / A1349930 / / 2757082-86-1 / [null] / 368.359 / C21H15F3N2O

Ambeed / (4R5R)-45-Diphenyl-2-(5-(trifluoromethyl)pyridin-2-yl)-45-dihydrooxazole / 100mg / 633418067 / A1349930 / / 2757082-86-1 / [null] / 368.359 / C21H15F3N2O

Medchemexpress LLC 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 274925-86-9 | MFCD09954136 | 99.9% | 273.24 | C14H11NO5 | 50 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor provided as a solid research compound for in vitro and in vivo studies. It is used to study COMT-mediated metabolism of L-DOPA and related pharmacology, and is supplied with characterization data and storage recommendations for experimental stability.

• Reversible COMT inhibitor for research use.
• Reported purity 99.9%.
• Molecular weight 273.24 g/mol.
• Physical form solid powder.
• High solubility in DMSO (≥100 mg/mL) and formulated in vivo solubility ≥2.5 mg/mL in 10% DMSO/40% PEG300/5% Tween-80/45% saline.
• Recommended storage 4°C protected from light; in solution store at -80°C up to 6 months or -20°C up to 1 month.